NCT00436371View on ClinicalTrials.gov

Amisulpride in Schizophrenic Acute Phase Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2006

Conditions

Schizophrenia

Interventions

DRUG

Amisulpride

Oral tablets

Trial Locations (1)

Unknown

Sanofi-Aventis, Hong Kong

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY